Skip to search formSkip to main contentSkip to account menu

AVE 0010

Known as: AVE-0010, AVE0010 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Objective: To review the pharmacology, pharmacokinetics, efficacy, and safety of the glucagon-like peptide-1 receptor agonist… 
Review
2017
Review
2017
Patients with a recent coronary event are at high risk of further cardiovascular events, including hospitalization for heart… 
Review
2016
Review
2016
Abstract: Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly being used for the treatment of… 
2016
2016
Lixisenatide (AVE0010) is a once-daily glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2 diabetes… 
2014
2014
This was a subanalysis of Japanese patients included in the glucagon‐like peptide‐1 receptor agonist AVE0010 in patients with… 
Highly Cited
2008
Highly Cited
2008
We recently showed that insulin analogues exhibit a beta-cell protective function. The aim of this study was to test if the anti…